Fundraising Fox
Latus
Philadelphia, US · Founded 2022 · 28 employees on LinkedIn · 10 known investors
Find your way into Latus
Sign up to find every way you can get introduced to Latus
- Your email: who you already know at Latus, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Latus team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.
Investors · 10
How we know: Hatch BioFund's portfolio page · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: biospace.com · Not right? Tell us
__Twitter.png)
How we know: biospace.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMay 2026
8VC (lead), Benjamin Franklin Technology Partners, BioAdvance, DCVC Bio, Gaingels, Hatch BioFund, Helen’s Pink Sky Foundation, Korea Development Bank, Modi Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Latus do?
- Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.
- Who are Latus's investors?
- Latus's investors include Hatch BioFund, 8VC, BioAdvance, DCVC (Data Collective), DCVC Bio, Gaingels, Korea Development Bank, Modi Ventures.
- Where is Latus headquartered?
- Latus is headquartered in Philadelphia, US.